|
|
| Vous vous trouvez dans - | Accueil-Analyses | - | Information professionnelle sur LEV DESITIN® solution concentrée pour perfusion |
| |
| Information professionnelle sur LEV DESITIN® solution concentrée pour perfusion: | Desitin Pharma GmbH | | | N03AX14 - Levetiracetam | ATC-DDD Version 2012. Source: WHO | | | | N03A - Antiepileptics | This group comprises preparations used in the treatment of epilepsy.
Combined preparations are classified at separate 5th levels using the corresponding 50-series.
The group is subdivided according to chemical structure.
| The DDDs for the antiepileptics are based on combination therapy.
|
| | N03AX - Other Antiepileptics | This group comprises antiepileptics, which cannot be classified in the preceding groups.
|
| | N03AX14 - Levetiracetam | | Concentr. | Adm.Route | Note |
|---|
| 1.5 g | O | | | 1.5 g | P | * | | 1.5 g | P | |
|
|
|
|
|
|
